Suppr超能文献

广角、扫频源光相干断层扫描血管造影测量值作为视网膜静脉阻塞抗血管内皮生长因子治疗的预测指标。

Widefield, Swept-Source Optical Coherence Tomography Angiography Metrics as Predictors of Anti-VEGF Treatment in Retinal Vein Occlusions.

出版信息

Ophthalmic Surg Lasers Imaging Retina. 2024 Jul;55(7):374-382. doi: 10.3928/23258160-20240208-02. Epub 2024 Mar 1.

Abstract

BACKGROUND AND OBJECTIVE

Our objective was to assess baseline widefield swept-source optical coherence tomography angiography (WF SSOCTA) microvascular metrics as predictors for the number of anti-vascular endothelial growth factor (VEGF) injections and visual acuity (VA) at 12-months follow-up in patients with retinal vein occlusion (RVO).

PATIENTS AND METHODS

This was a prospective study including 49 RVO eyes from 49 patients who had not received an anti-VEGF injection for at least 3 months prior to imaging. Microvascular metrics from 6×6-mm and 12×12-mm angiograms were assessed using linear regression models, adjusting for age.

RESULTS

Reductions in the vessel density (VD) and vessel skeletonized density (VSD) vascular metrics were associated both with a higher number of anti-VEGF injections at all follow-up time points and reduced VA 12 months after imaging in all RVO eyes.

CONCLUSIONS

WF SS-OCTA VD and VSD micro-vascular metrics at baseline can prognosticate VA and number of anti-VEGF injections required at 3, 6, and 12 months in RVO eyes. .

摘要

背景与目的

我们的目的是评估基线宽视野扫频源光相干断层扫描血管造影(WF SSOCTA)微血管指标,作为预测视网膜静脉阻塞(RVO)患者抗血管内皮生长因子(VEGF)注射次数和 12 个月随访时视力(VA)的指标。

患者与方法

这是一项前瞻性研究,纳入了 49 例 RVO 患者的 49 只眼,这些患者在成像前至少 3 个月未接受抗 VEGF 注射。使用线性回归模型评估 6×6mm 和 12×12mm 血管造影的微血管指标,并对年龄进行调整。

结果

在所有随访时间点,血管密度(VD)和血管骨架化密度(VSD)血管指标的降低均与 RVO 眼中抗 VEGF 注射次数的增加以及成像后 12 个月 VA 的降低相关。

结论

WF SS-OCTA 基线时的 VD 和 VSD 微血管指标可以预测 RVO 眼在 3、6 和 12 个月时所需的 VA 和抗 VEGF 注射次数。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验